A phase I study of alternate-day administration of S-1 plus leucovorin with bevacizumab in patients with refractory metastatic colorectal cancer.
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2631419
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: alternate-day administration of S-1 plus leucovorin with bevacizumab
Primary outcome(s): recommended dose
Study Design: Single arm Non-randomized
干预措施：采用替吉奥（S-1）联合亚叶酸钙（leucovorin）与贝伐珠单抗（bevacizumab）的隔日给药方案
主要结局指标：推荐剂量
研究设计：单臂非随机化研究
创建时间：
2015-01-15
